NYSE:MRK
Merck & Co., Inc.
Merck & Co., Inc.'s revenue grew 1.3% in fiscal 2025 to $65.0B. Free cash flow was $12.4B, 19.0% of revenue, and the diluted share count fell 1.3%.Summary generated from Merck & Co., Inc.'s SEC filings. Latest annual report filed Feb 24, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$65.0B
Revenue growth+1.3%
Revenue, 5-yr CAGR+9.4%
Gross margin74.8%
Operating marginn/a
Net margin28.1%
ROICn/a
Return on equity36.9%
Debt / equity0.93
Free cash flow$12.4B
FCF margin19.0%
Share count change−1.3%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 48.7 | 59.3 | 60.1 | 64.2 | 65.0 |
| Operating income | n/a | n/a | n/a | n/a | n/a |
| Net income | 13.0 | 14.5 | 0.4 | 17.1 | 18.3 |
| Free cash flow | 8.7 | 14.7 | 9.1 | 18.1 | 12.4 |
Recent filings
- 4Insider transaction report
Oct 1, 2026 - 4Insider transaction report
Oct 1, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 7, 2026 - 8-KResults of operations and financial condition
Aug 4, 2026 - 8-KResults of a shareholder vote
May 28, 2026 - 8-KOther events
May 22, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 4, 2026 - 8-KResults of operations and financial condition
Apr 30, 2026